Dr Terence Lim is a Senior Consultant Urologist with a subspecialty in Uro-Oncology. He is also the Medical Director at Assure Urology & Robotic Centre.
Prior to his private practice, Dr Terence Lim spent almost two decades in public healthcare. He served as the Senior Consultant and Chief of Department of Urology at Changi General Hospital (CGH). Dr Lim was also the director of CGH’s Advanced Surgical Centre, a committee dealing with complex surgeries, including robotic surgeries.
He operated on all three generations of the da Vinci Robotic Surgical System and is amongst the first few urologists in Singapore to operate using the latest generation of this technology. To date, he has been involved in over 700 robotic surgeries and was the first in Singapore to perform a Robot-assisted Retzius-sparing Prostatectomy.
Dr Lim has a keen interest in Endourological and Minimally Invasive Urological Surgeries and is experienced in complex laparoscopic and robot-assisted surgeries of kidneys and prostates like partial nephrectomies and radical prostatectomies.
Dr Chin Chong Min is a Consultant Urologist of 27 years’ experience. His urology training included a year at Bristol Urological Institute (BUI) in the United Kingdom (1996-1997), and a residency program in robotic urology at the University of California, Irvine (2005) in USA.
Dr Chin is renowned for his surgical expertise in uro-oncology, i.e. kidney, bladder, prostate and testicle cancer. He is versatile in both laparoscopic and robotic surgery. He has trained on the latest da Vinci Xi robot and is conversant with all three da Vinci robotic systems (viz. Standard, Si and Xi). His robotic experience includes over 800 prostate, 40 kidney and 6 adrenal surgeries. He has developed his own techniques in robotic surgery and presented two original videos of his robotic prostatectomy at the 2012 European Association of Urology Congress in Paris. His usual surgery time is 2 hours. The largest cancerous prostate he has removed is 120 gm, while the largest kidney tumour he has removed is 7 cm.
His other area of expertise is bladder dysfunction and urinary incontinence. He is one of the first urologists in Singapore to do sling surgery (TVT & TVT-O) for correcting stress incontinence. He is author of the 2nd edition of Clinical Handbook on Management of Incontinence (2001) and chairman of the committee which drafted the Clinical Practice Guidelines on ‘Management of Urinary Incontinence’ (2008).
In the endoscopic management of urinary stones, he is experienced in percutaneous nephrolithotripsy (PCNL) and laser ureteroscopy. Dr Chin also does laser prostatectomy (Greenlight laser) and has done more than 500 endoscopic prostate (TURP) surgeries.
Dr Pearllyn Quek graduated from the National University of Singapore in 1988 and was admitted to the Royal College of Surgeons (Glasgow) in February 1994. She was one of two females in Singapore to be first accredited a specialist in Urology in 2001. She further trained with Professor Chris Chapple in the Royal Hallamshire Hospital, Sheffield, UK, subspecialising in lower urinary tract disorders, urodynamics and reconstructive urology. She underwent a clinical fellowship in the world reknowned Institute of Nephrology and Urology, Mansoura, Egypt, receiving advanced training in bladder cancer surgery and neobladders.
A recognised expert in voiding disorders, she has authored book chapters, review articles and award winning papers on the subject. She is frequently invited to speak and conduct workshops both locally and internationally on the treatment of stress incontinence, urodynamics and bladder disorders.
Dr Pearllyn Quek has been in the EXCO of the Singapore Urological Association on several occasions and was the organising chairman for both the SUA Urology Fair 2005 and the 18th Video Urology World Congress 2007 in Singapore. She is very much involved in undergraduate and postgraduate surgical education and research and is a Clinical Lecturer with the National University of Singapore. Her current clinical interests include nocturia, the use of Botox in urology and voiding disorders and pelvic floor dysfunction. She continues to review articles for European Urology and the British Journal of Urology among others.
Dr Chong is the first Urologist trained in Southeast Asia to receive the prestigious full-time clinical Urologic Oncology Fellowship at Memorial-Sloan Kettering Cancer Center (MSKCC) in New York, USA.
He specialises in the prevention, diagnosis and treatment of prostate cancer, kidney cancer, bladder cancer, testis cancer and penile cancer.
Dr Chong is proficient in using the daVinci robotic systems operating in complex Robotic Cancer Surgery. His professional expertise also covers the traditional open and advanced laparoscopic key-hole methods in urology and oncology surgery.
Prior to proceeding for private practice, Dr Chong has been an educator, researcher and innovator. He was appointed as an Adjunct Assistant Professor at National University of Singapore (NUS), and the co-Director of Urologic Oncology, as well as Director of Research in the Department of Urology, at Tan Tock Seng Hospital (TTSH). His research interests include biomolecular cancer targets, precision medicine, nanoparticle therapy, bioimaging in molecular diagnosis of tumour, and development of novel biomedical devices.
With a vision to advocate holistic care for urological cancer patients, Dr Chong took up a variety of positions in TTSH. He served as the Chairman of the Urology Cancer Multidisciplinary Tumour Board, Chairman of Urology Cancer Support Programme, Chairman of Urology-Advance Care Planning (Uro-ACP) team, and Chairman of TTSH Prostate Cancer Support Group.